Disease Management
SugoSure targets patients with type 2 diabetes below 65 years old.
Also, British medtech company Smith+Nephew launches its robotics platform in India.
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
From mobile ECGs to tele-rehabilitation to defibrillator delivery drones, a range of new data was on display at the American Heart Association Scientific Sessions 2019.